Search My Trial (smt)

"Search My Trial (SMT)" is Japan's first clinical trial matching site that connects people suffering from various diseases and symptoms with clinical trial information across Japan. It matches each individual with suitable clinical trials from a vast database of nationwide clinical trial information.

Key features	Feature Overview
Clinical Trial Matching System	It connects patients with nearly all clinical trials and other study opportunities available in Japan.
Trial Information Across Japan	SMT pulls data from all major clinical trial public information databases in Japan, including JRCT, UMIN, Clinical.gov, and JAMCCT. It also provides access to a comprehensive database of over 500 different clinical trials and studies.
Search by Location	Easily find local clinical trials and studies by searching for the disease name.
Detailed Study Information	Easily view study overviews, eligibility criteria, and locations, and quickly apply for any trial that interests you.
Waiting List	With our waiting list feature, you can express interest in clinical trials or other studies that are not yet open for enrollment. Once your request is received, we will forward your anonymous information to the study sponsor or medical institution. *Please note that participation in the clinical trial is not guaranteed.
Seamlessly Complete via Web Screener	A quick 5-question web screening connects you with a clinical trial coordinator. *Further steps like call screenings and appointment scheduling may be needed.
Latest Disease-Specific Pages	Find everything from disease information to clinical trial updates on our specialized pages for each condition.
Email Notification	Users can register their preferred trial categories, clinical study types, and desired regions, and they will be notified by email when matching opportunities become available.

What is SMT for X?

This initiative utilizes the SMT platform to support smooth public information disclosure by university hospitals and other clinical trial facilities and pharmaceutical companies, as part of providing information on treatment options to patients and physicians (medical institutions) not involved in clinical trials, from the perspective of PPI (Patient and Public Involvement) and patient-centricity.

For medical institutions conducting clinical trials, such as university hospitals and cancer centers:
You can publicly disclose information about the clinical trials and clinical research being conducted at your institution to nearby medical institutions, patients, and their families, and provide support up to and including screening and participation.
We have already achieved success in supporting disclosure at national university hospitals and other institutions.

For pharmaceutical companies:
You can publicly disclose information about the clinical trials and clinical research being conducted at your company to patients and their families.
You can turn participation applications on or off for each disclosed clinical trial or clinical research. We have already achieved success in supporting disclosure at several major pharmaceutical companies both in Japan and overseas.

Introduction example

• 

  CLIC-D -Clinical Trial Information Center in Dementia-

  もの忘れ治験情報センター powerted by smt

  CLIC-D is a registry aimed at advancing dementia research. It connects registered individuals with clinical trials and studies, fostering the progress of dementia research in Japan. The CLIC-D secretariat is managed by buzzreach Co., Ltd. under commission from the National Center for Geriatrics and Gerontology.

• 

  smt for Boehringer Ingelheim

  smt for Boehringer Ingelheim

  Boehringer Ingelheim JP has launched a website to deliver clinical trial information to patients. The disclosure of clinical trial information is one of our efforts to achieve Patient and Public Involvement (PPI). We will continue to strive to improve the transparency and accessibility of information in order to realize trusted medical care.